Cita APA

Kiialainen, A., Adamkewicz, J., Petry, C., Oldenburg, J., Pipe, S. W., Young, G., . . . Schmitt, C. (2024). Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks.

Citación estilo Chicago

Kiialainen, Anna, et al. Pharmacokinetics and Coagulation Biomarkers in Children and Adults With Hemophilia A Receiving Emicizumab Prophylaxis Every 1, 2, or 4 Weeks. 2024.

Cita MLA

Kiialainen, Anna, et al. Pharmacokinetics and Coagulation Biomarkers in Children and Adults With Hemophilia A Receiving Emicizumab Prophylaxis Every 1, 2, or 4 Weeks. 2024.